Temat: "HIV" - OpacWWW - Prolib Integro

Skocz do pozycji: 21.

Tytuł:: The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study.
Autorzy:: Li B; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Lin X; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Chen S; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Qian Z; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Wu H; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Liao G; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Chen H; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Kang Z; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Peng J; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .
Liang G; Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Feb 12; Vol. 24 (1), pp. 440. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Journal Article
MeSH Terms:: Acquired Immunodeficiency Syndrome*
HIV Infections*/epidemiology
Humans ; Cross-Sectional Studies ; Coping Skills ; HIV ; Disease Progression ; Fear/psychology ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 22.

Tytuł:: Temporal Trends in Syphilis Incidence among Men with HIV in Busan, Korea, 2005-2022: A Retrospective Cohort Study.
Autorzy:: Lee SH; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan 49241, Republic of Korea.
Lee JE; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan 49241, Republic of Korea.
Lee SO; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan 49241, Republic of Korea.
Lee S; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan 49241, Republic of Korea.
Ko WS; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan 49241, Republic of Korea.
Kim HH; Department of Laboratory Medicine, Pusan National University School of Medicine, Busan 49241, Republic of Korea.; Biomedical Informatics Unit, Pusan National University School of Medicine, Busan 49241, Republic of Korea.
Shin KH; Department of Laboratory Medicine, Pusan National University School of Medicine, Busan 49241, Republic of Korea.
Kang JS; Department of Internal Medicine, Inje University College of Medicine, Busan 47392, Republic of Korea.
Son H; Department of Prevention Medicine, Donga University School of Medicine, Donga University Hospital, Busan 49201, Republic of Korea.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 07; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Syphilis*/complications
Syphilis*/epidemiology
Syphilis*/diagnosis
HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/diagnosis
Sexual and Gender Minorities*
Male ; Humans ; Adult ; Homosexuality, Male ; HIV ; Retrospective Studies ; Incidence ; Pandemics ; Risk Factors ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 23.

Tytuł:: Natural Polymorphisms D60E and I62V Stabilize a Closed Conformation in HIV-1 Protease in the Absence of an Inhibitor or Substrate.
Autorzy:: Tran TT; Department of Chemistry, University of Florida, Gainesville, FL 32611, USA.
Fanucci GE; Department of Chemistry, University of Florida, Gainesville, FL 32611, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 02; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
HIV Protease Inhibitors*/pharmacology
Humans ; Molecular Conformation ; Polymorphism, Genetic ; Molecular Dynamics Simulation ; HIV Protease/metabolism ; Mutation ; Protein Conformation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 24.

Tytuł:: HIV prevalence among children admitted with severe acute malnutrition and associated factors with mother-to-child HIV transmission at Mulago Hospital, Uganda: A mixed methods study.
Autorzy:: Musiime V; Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.; Research Department, Joint Clinical Research Centre, Kampala, Uganda.
Rujumba J; Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Kakooza L; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Namisanvu H; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Atuhaire L; Mwanamugimu Nutrition Unit, Directorate of Paediatrics and Child Care, Mulago National Referral Hospital, Kampala, Uganda.
Naguti E; Mwanamugimu Nutrition Unit, Directorate of Paediatrics and Child Care, Mulago National Referral Hospital, Kampala, Uganda.
Beinomugisha J; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Kiggwe A; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Nkinzi S; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Segawa I; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Matsiko N; Research Department, Joint Clinical Research Centre, Kampala, Uganda.
Babirekere-Iriso E; Mwanamugimu Nutrition Unit, Directorate of Paediatrics and Child Care, Mulago National Referral Hospital, Kampala, Uganda.
Musoke P; Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0301887. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Pregnancy Complications, Infectious*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/drug therapy
Severe Acute Malnutrition*/epidemiology
Infant ; Pregnancy ; Humans ; Female ; Male ; HIV ; Mothers ; Uganda/epidemiology ; Cross-Sectional Studies ; Prevalence ; Pandemics ; Infectious Disease Transmission, Vertical/prevention & control ; Hospitals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 25.

Tytuł:: Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.
Autorzy:: Darge T; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia. .
Babusha A; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Chilo D; Department of Pharmacy, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Dukessa A; Department of Biomedical Sciences, Institution of Health, Jimma University, Jimma, Ethiopia.
Teferi S; Department of Medical Laboratory Science, College of Health Sciences, Mettu University, Mettu, Ethiopia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 11; Vol. 14 (1), pp. 8473. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Coinfection*
Hepatitis C*/drug therapy
Liver Diseases*/etiology
Tuberculosis*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/etiology
Digestive System Diseases*/drug therapy
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Chemical and Drug Induced Liver Injury*/drug therapy
Adult ; Humans ; Antiretroviral Therapy, Highly Active/adverse effects ; Ethiopia/epidemiology ; Cross-Sectional Studies ; HIV ; Hepacivirus ; CD4 Lymphocyte Count

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 26.

Tytuł:: First-ever acute ischemic strokes in HIV-infected persons: A case-control study from stroke units.
Autorzy:: Stammler R; Department of Neurology and Stroke Unit, Rothschild Foundation Hospital, Paris, France.
Guillaume J; Clinical Research Unit, Rothschild Foundation Hospital, Paris, France.
Mazighi M; APHP, Department of Neurology and Stroke Unit, Lariboisière Hospital, and Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France.
Denier C; APHP, Department of Neurology and Stroke Unit, Hôpital Bicêtre, Paris Saclay University, Le Kremlin-Bicêtre, France.
Raynouard I; Department of Neurology and Stroke Unit, Rothschild Foundation Hospital, Paris, France.
Lapergue B; Department of Neurology and Stroke Unit, Foch Hospital, Versailles Saint-Quentin-en-Yvelines University, Suresnes, France.
De Broucker T; Department of Neurology and Stroke Unit, Delafontaine Hospital, Saint-Denis, France.
Meseguer E; APHP, Department of Neurology and Stroke Unit, Bichat-Claude-Bernard Hospital, INSERM LVTS-U1148, DHU FIRE, University of Paris, Paris, France.
Hosseini H; APHP, Department of Neurology and Stroke Unit, Henri-Mondor Hospital, University of Paris XII, Créteil, France.
Leger A; APHP, Stroke Unit, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.
Smadja D; Department of Neurology and Stroke Unit, Centre Hospitalier Sud-Francilien, Paris Saclay University, Corbeil-Essonnes, France.
Lamy C; Neurology Department and Stroke Unit, GHU Paris Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
Obadia M; Department of Neurology and Stroke Unit, Rothschild Foundation Hospital, Paris, France.
Moulignier A; Department of Neurology and Stroke Unit, Rothschild Foundation Hospital, Paris, France.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 916-925. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Journal Article
MeSH Terms:: Ischemic Stroke*/epidemiology
Ischemic Stroke*/etiology
Ischemic Stroke*/therapy
Brain Ischemia*/epidemiology
Brain Ischemia*/therapy
Brain Ischemia*/complications
Stroke*/epidemiology
Stroke*/etiology
Stroke*/therapy
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hypertension*/complications
Humans ; Case-Control Studies ; HIV ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 27.

Tytuł:: Development and validation of the information-motivation-behavioural skills model-based human immunodeficiency virus education kit for adolescents in Malaysia.
Autorzy:: Wan Mohamad Darani WNS; Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.; Training Management Division, Ministry of Health, Putrajaya, Malaysia.
Mat Ruzlin AN; Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
Azhar ZI; Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
Chen XW; Department of Public Health Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia. .; Institute of Medical Molecular Biotechnology (IMMB), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 22; Vol. 14 (1), pp. 6890. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Information Motivation Behavioral Skills Model*
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Humans ; Adolescent ; Malaysia ; Attitude ; Receptor Protein-Tyrosine Kinases ; HIV

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 28.

Tytuł:: Effectiveness of human immunodeficiency virus prevention strategies by mapping the geographic dispersion pattern of human immunodeficiency virus prevalence in Nanning, China.
Autorzy:: Cen P; Nanning Center for Disease Control and Prevention, Nanning, 530023, Guangxi, China.; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Science Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xu G; Nanning Survey and Design Institute Group Co., Ltd., Nanning, 530022, Guangxi, China.
Wu J; Nanning Survey and Design Institute Group Co., Ltd., Nanning, 530022, Guangxi, China.
Qin J; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
He J; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Deng X; Nanning Center for Disease Control and Prevention, Nanning, 530023, Guangxi, China.
Yang X; Nanning Center for Disease Control and Prevention, Nanning, 530023, Guangxi, China.
Lu P; Nanning Survey and Design Institute Group Co., Ltd., Nanning, 530022, Guangxi, China.
Nong M; Nanning Center for Disease Control and Prevention, Nanning, 530023, Guangxi, China.
Jiang J; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Science Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Ye L; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Science Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Tang H; Nanning Center for Disease Control and Prevention, Nanning, 530023, Guangxi, China. .
Liang B; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China. .; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Science Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China. .
Liang H; Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China. .; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Science Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China. .; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Mar 16; Vol. 24 (1), pp. 831. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/epidemiology
HIV Infections*/prevention & control
Acquired Immunodeficiency Syndrome*/epidemiology
Humans ; HIV ; Prevalence ; China/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 29.

Tytuł:: Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg.
Autorzy:: Meschi S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Mizzoni K; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Leoni BD; Validation & Verification, Core Laboratory, Abbott, 00144 Rome, Italy.
Galli C; Independent Researcher, 00139 Rome, Italy.
Garbuglia AR; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Belladonna S; Abbott Molecular, Abbott, 00144 Rome, Italy.
Girardi E; Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Maggi F; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
The Hbsagn Study Group; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 07; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis B, Chronic*
Humans ; Hepatitis B virus/genetics ; Hepacivirus/genetics ; Hepatitis B Surface Antigens ; DNA, Viral ; HIV/genetics ; Hepatitis B Antibodies ; Prevalence ; Biomarkers ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 30.

Tytuł:: Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
Autorzy:: Roucoux G; ECEVE, UMR-S 1123, Inserm, Université Paris Cité, Paris, France.; Patient-Reported Outcomes Research (PROQOL), Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Hôpital Hôtel-Dieu, AP-HP, Paris, France.
Thonon F; ECEVE, UMR-S 1123, Inserm, Université Paris Cité, Paris, France.; Patient-Reported Outcomes Research (PROQOL), Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Hôpital Hôtel-Dieu, AP-HP, Paris, France.
Zucman D; Foch Hospital, Suresnes, France.
Rey D; Trait d'Union-Strasbourg University Hospitals, Strasbourg, France.
Abgrall S; Hôpital Antoine Béclère, Service de Médecine Interne, Clamart, France.; UVSQ, INSERM U1018, CESP, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Eriksson LE; Karolinska Institute, Solna, Sueden.
Préau M; Inserm Unit 1296 « Radiations: Defense, Health, Environment », Lyon, France.; Lyon 2 Lumière University, Lyon, France.
Michels D; AIDES (French HIV/AIds and Viral Hepatites Organization), Pantin, France.; Laboratoire de Recherche Communautaire, Coalition PLUS, Pantin, France.
Chéret A; Outpatient Medicine Service, University Hospital, Pointe-à-Pitre, Guadeloupe, France.; Internal Medicine Unit, Cochin Hospital, Paris, France.
Duracinsky M; ECEVE, UMR-S 1123, Inserm, Université Paris Cité, Paris, France.; Patient-Reported Outcomes Research (PROQOL), Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Hôpital Hôtel-Dieu, AP-HP, Paris, France.; Internal Medicine Unit, Le Kremlin Bicêtre Hospital, Bicêtre, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0295223. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Male ; Humans ; Middle Aged ; HIV ; SARS-CoV-2 ; COVID-19 Drug Treatment ; COVID-19 Testing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 31.

Tytuł:: Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics.
Autorzy:: Zhang CX; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Conrad TM; Emmes, Rockville, Maryland, USA.
Hermann D; Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Gordon MA; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Houpt E; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Iroh Tam PY; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, UK.
Jere KC; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Nedi W; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Operario DJ; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Phulusa J; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Quinnan GV Jr; Emmes, Rockville, Maryland, USA.
Sawyer LA; Emmes, Rockville, Maryland, USA.
Barrett LK; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
Thole H; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Toto N; Liverpool School of Tropical Medicine, Liverpool, UK.
Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
Arnold SLM; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 410-423. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cryptosporidiosis*
Cryptosporidium*
HIV Infections*/complications
HIV Infections*/drug therapy
Adult ; Humans ; Clofazimine/pharmacokinetics ; Clofazimine/therapeutic use ; Diarrhea/drug therapy ; HIV ; Clinical Trials, Phase II as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 32.

Tytuł:: MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV.
Autorzy:: Alpuche-Lazcano SP; Virus-Cell Interactions Laboratory, Lady Davis Institute for Medical Research, 3999, Côte Ste Catherine St., Montréal, QC, H3T 1E2, Canada.; Department of Medicine, Division of Experimental Medicine, McGill University, Montréal, QC, H4A 3J1, Canada.; National Research Council Canada, Montréal, QC, H4P 2R2, Canada.
Scarborough RJ; Virus-Cell Interactions Laboratory, Lady Davis Institute for Medical Research, 3999, Côte Ste Catherine St., Montréal, QC, H3T 1E2, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, H3A 2B4, Canada.
Gatignol A; Virus-Cell Interactions Laboratory, Lady Davis Institute for Medical Research, 3999, Côte Ste Catherine St., Montréal, QC, H3T 1E2, Canada. .; Department of Medicine, Division of Experimental Medicine, McGill University, Montréal, QC, H4A 3J1, Canada. .; Department of Medicine, Division of Infectious Diseases, McGill University, Montréal, QC, H4A 3J1, Canada. .; Department of Microbiology and Immunology, McGill University, Montréal, QC, H3A 2B4, Canada. .; Pokaż więcej
Źródło:: Retrovirology [Retrovirology] 2024 Feb 29; Vol. 21 (1), pp. 5. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article; Review
MeSH Terms:: MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
HIV Infections*
Humans ; HIV ; Gene Expression Regulation ; RNA, Untranslated/genetics ; Deltaretrovirus ; Retroviridae/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 33.

Tytuł:: External quality assessment to support the WHO ProSPeRo study for the evaluation of two dual HIV/syphilis point-of-care tests in seven countries.
Autorzy:: Cao W; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA. .
Fakile YF; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Shukla MR; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Pettus K; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Lupoli K; Division of Global HIV &TB, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hong J; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Pillay A; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Kularatne R; Centre for HIV & STI, National Institute for Communicable Diseases, Johannesburg, South Africa.
Oumzil H; National Reference Laboratory for HIV, Virology Department, National Institute of Hygiene, and Pedagogy and Research Unit of Microbiology, School of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco.
Padovese V; Genitourinary Clinic, Department of Dermatology and Venereology, Mater Dei Hospital, Msida, 2090, Malta.
Sherriff N; School of Sport and Health Sciences, University of Brighton, Brighton, UK.
SSewanyana I; Central Public Health Laboratories, Ministry of Health, Plot 1062, 106 Old Butabika Rd, Kampala, Uganda.
Vargas SK; Center for Interdisciplinary Research in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
Zorzi A; Virology and Microbiology Unit, Department of Pathology and Diagnostics, Verona University Hospital, Verona, Italy.; Virology and Microbiology Unit, Department of Molecular Medicine, Padua University Hospital, Padua, Italy.
Blondeel K; Department of Sexual and Reproductive Health and Research, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Toskin I; Department of Sexual and Reproductive Health and Research, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.
Kersh EN; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 29; Vol. 24 (Suppl 1), pp. 194. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Syphilis*
HIV Infections*/diagnosis
HIV-1*
Humans ; Treponema pallidum ; HIV Antibodies ; Sensitivity and Specificity ; Antibodies, Bacterial ; Point-of-Care Testing ; Syphilis Serodiagnosis/methods ; HIV-2 ; World Health Organization ; Point-of-Care Systems

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 34.

Tytuł:: Reshaping the narrative: Tracing the historical trajectory of HIV/AIDS, gay men, and public health in Sweden.
Autorzy:: Nyman F; Department of Psychology and Social Work, Mid Sweden University, Östersund, Jämtland, Sweden.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 22; Vol. 19 (2), pp. e0298630. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/epidemiology
HIV Infections*/prevention & control
Acquired Immunodeficiency Syndrome*/epidemiology
Acquired Immunodeficiency Syndrome*/prevention & control
Sexual and Gender Minorities*
Male ; Humans ; HIV ; Public Health ; Quality of Life ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 35.

Tytuł:: "They call me the 'Great Queen'": implementing the Malkia Klabu program to improve access to HIV self-testing and contraception for adolescent girls and young women in Tanzania.
Autorzy:: Willard-Grace R; Center for Excellence in Primary Care, University of California, San Francisco, San Francisco, CA, USA. .
Abigail Cabrera F; Center for Excellence in Primary Care, University of California, San Francisco, San Francisco, CA, USA.
Bykhovsky C; Center for Excellence in Primary Care, University of California, San Francisco, San Francisco, CA, USA.
Douglas K; Center for Excellence in Primary Care, University of California, San Francisco, San Francisco, CA, USA.
Hunter LA; School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Mnyippembe A; Health for a Prosperous Nation, Dar Es Salaam, Tanzania.
Mgunya KH; Health for a Prosperous Nation, Dar Es Salaam, Tanzania.
McCoy SI; School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Liu JX; Institute for Health and Aging, Bixby Center for Global Reproductive Health, University of California, San Francisco, San Francisco, CA, USA.; Pokaż więcej
Źródło:: Reproductive health [Reprod Health] 2024 Feb 07; Vol. 21 (1), pp. 21. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Adolescent ; Female ; Humans ; Contraception ; HIV ; Self-Testing ; Tanzania

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 36.

Tytuł:: Modeling and Analysis of HIV-1 Pol Polyprotein as a Case Study for Predicting Large Polyprotein Structures.
Autorzy:: Hao M; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Imamichi T; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Chang W; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 02; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV-1*/genetics
HIV-1*/metabolism
pol Gene Products, Human Immunodeficiency Virus*/chemistry
Humans ; Gene Products, pol/genetics ; Gene Products, pol/metabolism ; HIV Protease/genetics ; HIV Protease/metabolism ; Polyproteins/genetics ; RNA-Directed DNA Polymerase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 37.

Tytuł:: Modeling resistance to the broadly neutralizing antibody PGT121 in people living with HIV-1.
Autorzy:: Cassidy T; School of Mathematics, University of Leeds, Leeds, United Kingdom.
Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Perelson AS; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.; Pokaż więcej
Źródło:: PLoS computational biology [PLoS Comput Biol] 2024 Mar 29; Vol. 20 (3), pp. e1011518. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
HIV-1*
Humans ; Antibodies, Neutralizing/therapeutic use ; Broadly Neutralizing Antibodies ; HIV Antibodies ; Models, Theoretical

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 38.

Tytuł:: Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART.
Autorzy:: Sakoi-Mosetlhi M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Ajibola G; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Haghighat R; Harvard Medical School, Boston, Massachusetts, United States of America.
Batlang O; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Maswabi K; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Pretorius-Holme M; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Powis KM; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Lockman S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
Makhema J; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Litcherfeld M; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
Kuritzkes DR; Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Shapiro R; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0299942. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:: Evaluation Study; Journal Article
MeSH Terms:: HIV Infections*
HIV-1*
Child ; Female ; Humans ; Antibodies, Neutralizing ; Botswana ; Broadly Neutralizing Antibodies/therapeutic use ; Caregivers ; HIV Antibodies/therapeutic use ; Mothers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 39.

Tytuł:: HIHISIV: a database of gene expression in HIV and SIV host immune response.
Autorzy:: Costa RL; DEXL Lab, National Laboratory for Scientific Computing, Petrópolis, Brazil. .
Gadelha L; German Human Genome-Phenome Archive (GHGA, W620), German Cancer Research Center (DKFZ), Heidelberg, Germany. .
D'arc M; Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Ribeiro-Alves M; Instituto Nacional de Infectologia Evandro Chagas, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Robertson DL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.
Schwartz JM; Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.
Soares MA; Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 21941-902, Brazil.; Programa de Oncovirologia, Divisão de Pesquisa Translacional, Instituto Nacional do Câncer, Rio de Janeiro, 20230-130, Brazil.
Porto F; DEXL Lab, National Laboratory for Scientific Computing, Petrópolis, Brazil.; Pokaż więcej
Źródło:: BMC bioinformatics [BMC Bioinformatics] 2024 Mar 22; Vol. 25 (1), pp. 125. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Simian Immunodeficiency Virus*/genetics
Simian Acquired Immunodeficiency Syndrome*/genetics
HIV Infections*
Animals ; Humans ; HIV ; Disease Progression ; Immunity ; Gene Expression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 40.

Tytuł:: Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
Autorzy:: Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Dintwe OB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.
Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Naicker N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa; and Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Jani I; Instituto Nacional de Saude, Maputo, Mozambique.
Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Hunidzarira P; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
Sebe M; Aurum Institute, Tembisa, Gauteng, South Africa.
Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Polakowski L; DAIDS, NIAID, NIH, Bethesda, Maryland, United States of America.
Ramirez S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Nebergall M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Sikhosana L; Hutchinson Centre Research Institute of South Africa, Johannesburg, South Africa.
Heptinstall J; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
Seaton KE; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Diazgranados CA; Formerly Sanofi-Pasteur, Swiftwater, Pennsylvania, Pennsylvania, United States of America.
Koutsoukos M; GSK, Wavre, Belgium.
Van Der Meeren O; Previously GSK, Rixensart, Belgium.
Barnett SW; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
Kanesa-Thasan N; Formerly GSK, Rockville, Maryland, United States of America.
Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Tomaras GD; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Mngadi K; Aurum Institute, Tembisa, Gauteng, South Africa.
Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Pokaż więcej
Corporate Authors:: HVTN 107 Protocol Team
Źródło:: PLoS medicine [PLoS Med] 2024 Mar 19; Vol. 21 (3), pp. e1004360. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Typ publikacji:: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms:: AIDS Vaccines*/adverse effects
Alum Compounds*
HIV Infections*/prevention & control
HIV-1*
Polysorbates*
Squalene*
Adult ; Humans ; Adjuvants, Immunologic ; HIV Antibodies ; Immunogenicity, Vaccine ; Immunoglobulin A ; Immunoglobulin G ; Vaccines, Combined ; Vaccines, Synthetic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""HIV"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji